Asp Isotopes [ASPI] vs Huntsman [HUN] Detailed Stock Comparison
Asp Isotopes
NASDAQ
Loading...
Huntsman
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Asp Isotopes wins in 7 metrics, Huntsman wins in 11 metrics, with 0 ties. Huntsman appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Asp Isotopes | Huntsman | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -14.17 | 46.18 | Asp Isotopes |
| Price-to-Book Ratio | 15.14 | 0.54 | Huntsman |
| Debt-to-Equity Ratio | 84.08 | 74.27 | Huntsman |
| PEG Ratio | -59.53 | 10.96 | Asp Isotopes |
| EV/EBITDA | -23.83 | 10.39 | Asp Isotopes |
| Profit Margin (TTM) | 38.60% | -2.63% | Asp Isotopes |
| Operating Margin (TTM) | -721.89% | 0.64% | Huntsman |
| EBITDA Margin (TTM) | N/A | 0.64% | N/A |
| Return on Equity | -115.46% | -2.19% | Huntsman |
| Return on Assets (TTM) | -26.14% | 0.81% | Huntsman |
| Free Cash Flow (TTM) | $-28.07M | $79.00M | Huntsman |
| 1-Year Return | 313.43% | -59.03% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 185.28 | 0.27 | Huntsman |
| Enterprise Value | $666.51M | $3.93B | Huntsman |
| EV/Revenue Ratio | 151.29 | 0.66 | Huntsman |
| Gross Profit Margin (TTM) | 29.67% | 14.26% | Asp Isotopes |
| Revenue per Share (TTM) | $0 | $35 | Huntsman |
| Earnings per Share (Diluted) | $-0.59 | $-0.78 | Asp Isotopes |
| Beta (Stock Volatility) | 3.38 | 0.72 | Huntsman |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Asp Isotopes vs Huntsman Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Asp Isotopes | -1.54% | -14.71% | 27.57% | 65.37% | 55.30% | 80.77% |
| Huntsman | -5.05% | -17.69% | -16.73% | -31.11% | -43.01% | -47.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Asp Isotopes | 313.43% | 218.93% | 218.93% | 218.93% | 218.93% | 218.93% |
| Huntsman | -59.03% | -68.15% | -53.48% | -46.89% | -11.70% | -57.36% |
Performance & Financial Health Analysis: Asp Isotopes vs Huntsman
| Metric | ASPI | HUN |
|---|---|---|
| Market Information | ||
| Market Cap | $816.25M | $1.60B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,793,356 | 6,035,103 |
| 90 Day Avg. Volume | 4,457,119 | 4,815,691 |
| Last Close | $8.93 | $9.21 |
| 52 Week Range | $1.86 - $10.82 | $9.03 - $25.12 |
| % from 52W High | -17.47% | -63.34% |
| All-Time High | $10.82 (Jul 25, 2025) | $41.65 (Feb 21, 2022) |
| % from All-Time High | -17.47% | -77.89% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | -0.04% |
| Quarterly Earnings Growth | 0.31% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.39% | -0.03% |
| Operating Margin (TTM) | -7.22% | 0.01% |
| Return on Equity (TTM) | -1.15% | -0.02% |
| Debt to Equity (MRQ) | 84.08 | 74.27 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.59 | $17.10 |
| Cash per Share (MRQ) | $0.75 | $1.92 |
| Operating Cash Flow (TTM) | $-16,894,872 | $254.00M |
| Levered Free Cash Flow (TTM) | $-20,013,620 | $150.62M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Asp Isotopes vs Huntsman
| Metric | ASPI | HUN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -14.17 | 46.18 |
| Forward P/E | -59.53 | 10.96 |
| PEG Ratio | -59.53 | 10.96 |
| Price to Sales (TTM) | 185.28 | 0.27 |
| Price to Book (MRQ) | 15.14 | 0.54 |
| Market Capitalization | ||
| Market Capitalization | $816.25M | $1.60B |
| Enterprise Value | $666.51M | $3.93B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 151.29 | 0.66 |
| Enterprise to EBITDA | -23.83 | 10.39 |
| Risk & Other Metrics | ||
| Beta | 3.38 | 0.72 |
| Book Value per Share (MRQ) | $0.59 | $17.10 |
Financial Statements Comparison: Asp Isotopes vs Huntsman
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASPI | HUN |
|---|---|---|
| Revenue/Sales | $1.10M | $1.41B |
| Cost of Goods Sold | $774,765 | $1.21B |
| Gross Profit | $326,840 | $201.00M |
| Research & Development | $1.53M | $32.00M |
| Operating Income (EBIT) | $-7.95M | $10.00M |
| EBITDA | $-8.23M | $83.00M |
| Pre-Tax Income | $-8.53M | $27.00M |
| Income Tax | $-70,720 | $15.00M |
| Net Income (Profit) | $-8.46M | $11.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASPI | HUN |
|---|---|---|
| Cash & Equivalents | $55.97M | $334.00M |
| Total Current Assets | $59.03M | $2.29B |
| Total Current Liabilities | $8.18M | $1.54B |
| Long-Term Debt | $36.96M | $2.01B |
| Total Shareholders Equity | $45.73M | $3.17B |
| Retained Earnings | $-64.62M | $2.19B |
| Property, Plant & Equipment | $1.02M | $2.88B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASPI | HUN |
|---|---|---|
| Operating Cash Flow | $-7.16M | $-124.00M |
| Capital Expenditures | $-2.36M | N/A |
| Free Cash Flow | $-5.53M | $-110.00M |
| Debt Repayment | $-262,304 | $-319.00M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | ASPI | HUN |
|---|---|---|
| Shares Short | 16.34M | 9.04M |
| Short Ratio | 4.67 | 2.12 |
| Short % of Float | 0.24% | 0.06% |
| Average Daily Volume (10 Day) | 4,793,356 | 6,035,103 |
| Average Daily Volume (90 Day) | 4,457,119 | 4,815,691 |
| Shares Outstanding | 72.07M | 172.14M |
| Float Shares | 54.53M | 153.89M |
| % Held by Insiders | 0.23% | 0.06% |
| % Held by Institutions | 0.37% | 0.89% |
Dividend Analysis & Yield Comparison: Asp Isotopes vs Huntsman
| Metric | ASPI | HUN |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.46 |
| 3-Year Avg Dividend Yield | N/A | 0.88% |
| 3-Year Total Dividends | N/A | $1.38 |
| Ex-Dividend Date | N/A | Dec 14, 2023 |